This study is currently not recruiting participants.
A Phase II/III Randomized Double-blind Placebo-Controlled Multi-Center Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer?s Disease
Primary Investigator
J
Jared Brosch, MD
Primary Investigator
Not Recruiting
18 years - 80 years
All
Phase
N/A
1 Location
Brief description of study
The purpose of this research study is to test two potential disease modifying therapies versus placebo for the treatment of Alzheimer?s disease to determine if one or both prevent, delay, or reverse the changes in the brain that are associated with the development of disease symptoms.
Detailed description of study
The purpose of this research study is to test two potential disease modifying therapies versus placebo for the treatment of Alzheimer?s disease to determine if one or both prevent, delay, or reverse the changes in the brain that are associated with the development of disease symptoms.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Alzheimer's Disease
Age:
18 years - 80 years
Gender: All
Inclusion Criteria Diagnosed with one of the Alzheimer gene mutations Exclusion Criteria Diagnosed with another disorder of the central nervous system Diagnosed with HIV or hepatitis B or C History of cancer Currently pregnant
Updated on
01 Aug 2024.
Study ID: 1307011925
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
